About: Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2018 (uk) im August 2018 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57927969-B0CBAFA2-F2E3-44B6-964D-1CF395EFD3F9
publication date	2018-08-13 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57927969-2AA1A708-0546-4621-9A4A-26A417CF33B9
language of work or name	English
exact match	wds:Q57927969-C2533F3C-224A-4946-A1A8-30EB2775F682
exact match	https://scigraph.springernature.com/pub.10.1186/s40249-018-0461-0
cites work	wds:Q57927969-095D0EB1-034E-489B-AEF7-8749A0C37550 wds:Q57927969-0B44631A-AD91-4BB9-80BE-47B9278E08C3 wds:Q57927969-1487D04E-3581-4901-94AB-483C1A6A6759 wds:Q57927969-14E007E5-D0FE-4BBF-B87A-0FDBFF362C8A wds:Q57927969-2FC04069-7FC6-4F04-8D52-093ECA7BE065 wds:Q57927969-4DF8192F-682E-4EA7-AA4E-2847D28AE6EA wds:Q57927969-8441F30B-358A-4872-B9B5-098B40522D63 wds:Q57927969-8D28E381-EDC7-48CB-AF13-65DCCFC2B1F3 wds:Q57927969-90494A58-9034-446E-993E-2714DBDA1112 wds:Q57927969-95AC48FC-65F1-42AF-9AF1-DEEA4BB011F2 wds:Q57927969-AB525EF4-4E99-49F9-878D-AED12FE02865 wds:Q57927969-BAB54BC4-BA9B-42C2-B997-13C49586D3A0 wds:Q57927969-CAF649CE-A00C-4A7F-AD61-99D40D3E027E wds:Q57927969-D92787B7-BE5F-4607-A02C-687DF4E7DE39 wds:Q57927969-E6A5417A-24AD-42C4-8EC7-485E73677278
cites work	Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis Single-dose liposomal amphotericin B for visceral leishmaniasis in India Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh Phase 4 pharmacovigilance trial of paromomycin injection for the treatment of visceral leishmaniasis in India Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis Leishmaniasis worldwide and global estimates of its incidence Visceral leishmaniasis-associated mortality in Bangladesh: a retrospective cross-sectional study Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis Investments in Research and Surveillance Are Needed to Go Beyond Elimination and Stop Transmission of Leishmania in the Indian Subcontinent Pharmacovigilance methods in public health programmes: the example of miltefosine and visceral leishmaniasis AmBisome Induced Avascular Necrosis of the Alae of the Nose of a very young girl suffering from Kala-azar - a Case Report Pharmacovigilance of Miltefosine in Treatment of Visceral Leishmaniasis in Endemic Areas of Bihar, India
author name string	wds:Q57927969-0C1E10AA-3C6A-48D3-9854-1143661F2723 wds:Q57927969-41198DBD-5986-4213-86B2-0979EAF719AD wds:Q57927969-6DC189E7-F415-4F02-8AD0-DA6F03EEB0A5 wds:Q57927969-8C7D9425-359A-439A-A448-FB8A595C87DA wds:Q57927969-A78A468F-F9A2-40E4-B688-C59E58156D65 wds:Q57927969-BE401D0A-9B5C-411C-B9BC-B3786D6C126F wds:Q57927969-C3BDEB01-F5B8-472B-8FC7-5BB2A5EDF4A5 wds:Q57927969-C67A0B52-2D6D-4DA5-9EAC-42DC4A6CCBED wds:Q57927969-DB65DD9C-357E-41C7-90D9-97CAAAE95520 wds:Q57927969-E934CC13-3927-45D2-A1E9-F9D3A4201D16
author name string	Amresh Kumar Varun Sharma Prakash Ghosh A K M Shamsuzzaman Vivek Ahuja Md Sakhawat Hossain Abhijit Sharma A F M Akhtar Hossain Md Akter Hossain Md Mahshin
rdfs:label	Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme (en) Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme (nl)
skos:prefLabel	Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme (en) Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme (nl)
name	Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme (en) Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme (nl)
author	wds:Q57927969-682A6914-FFFA-4AE3-B6B1-E6ABFD6F71B9 wds:Q57927969-CD3B80EE-4943-49A7-91FE-9F907744F7BF wds:Q57927969-F259FE77-ADDD-4DFD-80F5-2B799DB005D4
author	Dinesh Mondal Rashidul Haque Shomik Maruf
title	wds:Q57927969-687B2A77-1A54-401D-A728-0DB838A0942E
title	Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme (en)
page(s)	wds:Q57927969-707F99A3-87B0-495C-96F6-E47A15CF184B
page(s)	80
instance of	wds:Q57927969-81BD26B8-F054-4084-A849-9B3B043DDEC6
instance of	scholarly article
main subject	wds:Q57927969-28B58757-ACC0-4DD0-A826-A0D91C6E1BFE wds:Q57927969-B569EC72-DB99-4A6B-9767-A604226EC12A
main subject	Bangladesh visceral leishmaniasis
PubMed ID	wds:Q57927969-43100867-9194-4D9A-9DB3-0DB917B9EA05
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30099967
PubMed ID	30099967
published in	wds:Q57927969-7D0671EE-BC03-4800-BCBE-8A96177A73B5
published in	Infectious Diseases of Poverty
issue	wds:Q57927969-9EBA30F2-6A5C-40C8-BB8A-F1D47378630A
volume	wds:Q57927969-1A19C338-C30B-4681-A866-06E53F2CD0AB
issue	1
volume	7
DOI	wds:Q57927969-070DEE10-8689-4255-8981-141AC82432C8
DOI	http://dx.doi.org/10.1186/S40249-018-0461-0
DOI	10.1186/S40249-018-0461-0
copyright license	wds:Q57927969-b945e81e-104f-4c52-8216-6244bc02625b
copyright status	wds:Q57927969-f87b9b72-ee48-48a4-b8e6-d30d963c4836
copyright license	Creative Commons Attribution 4.0 International
copyright status	copyrighted
PMCID	wds:Q57927969-7425BE2A-8852-426B-9867-5A24589B1359
PMCID	6088425

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software